Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer

You Yuan; Rossi Michael J.

首页> 外文期刊>In Vitro Cellular and Developmental Biology. Animal: Journal of the Tissues Culture Association >Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer

【24h】

Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer

机译：菠萝蛋白蛋白作为三重阴性乳腺癌的新疗法靶标

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《In Vitro Cellular and Developmental Biology. Animal: Journal of the Tissues Culture Association》 |2017年第7期|共1页
作者
You Yuan; Rossi Michael J.;
展开▼
作者单位

Univ New Haven Dept Biol &

Environm Sci West Haven CT USA;

Univ New Haven Dept Biol &

Environm Sci West Haven CT USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类动物学;细胞生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer [J] . You Yuan, Rossi Michael J. In Vitro Cellular and Developmental Biology. Animal: Journal of the Tissues Culture Association . 2017,第7期

机译：菠萝蛋白蛋白作为三重阴性乳腺癌的新疗法靶标
2. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer [J] . CabezónT., GromovaI., GromovP., Molecular & cellular proteomics: MCP . 2013,第2期

机译：三阴性乳腺癌的蛋白质组学分析与三层正交技术方法相结合，确定了Mage-A4是雌激素受体阴性乳腺癌的潜在治疗靶标
3. Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer [J] . Zheng Pengfei, Zhang Yifu, Zhang Bin, Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie . 2018,第期

机译：合成人单克隆抗体靶向HIL1受体辅助蛋白链，具有三阴性乳腺癌治疗潜力
4. Drug Discovery Targeting PRC2 to Alter Epigenetics for Therapeutics of Triple Negative Breast Cancer [C] . Duxin Sun International Forum on Leading Edge Technologies on Crystallization Engineering and Pharmaceutics Development;Tianjin University;Tianjin Medical University . -1

机译：药物发现靶向PRC2以改变三重阴性乳腺癌治疗的表观遗传学
5. Identification of LRP8, CDCA7, and MLK4 as Novel Therapeutic Targets for Cancer Stem Cells in Triple-negative Breast Cancer [D] . Lin, Chang-Ching. 2018

机译：鉴定LRP8，CDCA7和MLK4作为三阴性乳腺癌中癌症干细胞的新疗法靶标
6. Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells [O] . Sylvia S. Gayle, Jennifer M. Sahni, Bryan M. Webb, 2019

机译：靶向BCL-xL可引起衰老细胞死亡从而改善三阴性乳腺癌中bromodomain和末端蛋白抑制剂的功效
7. Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases [O] . Jennifer M. Sahni, Sylvia S. Gayle, Kristen L. Weber Bonk, 2016

机译：溴琼蛋白抑制通过抑制Aurora激酶来阻断三阴性乳腺癌的生长
8. PPAR Delta as a Therapeutic Target in Triple-Negative Breast Cancers. [R] . Qi, C. 2012

机译：ppaR Delta作为三阴性乳腺癌的治疗靶点。

Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer

著录项

相似文献

相关主题

期刊订阅